Traitements2programmes
Essais1liés
Publications5liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
RNS® SystemThe RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepileptic medications. Candidates will continue to receive their epilepsy medications while participating in the trial. Épilepsie Phase 4 À vérifier United States À vérifier
RNS® SystemThe RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepileptic medications. Candidates will continue to receive their epilepsy medications while participating in the trial. Épilepsie Phase 4 À vérifier United States À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
RNS® System Épilepsie Phase 4 NCT00572195 RNS® System LTT Study COMPLETED

Publications

5
MoléculeIndication / populationTitreJournalDate
RNS® System Clusters in Thalamic iEEG Spectral Features Reveal Sleep/Wake Differences Over Time. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
RNS® System Numerical investigations around the Gallavotti-Cohen fluctuation theorem on log-lattices. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences
RNS® System Responsive neurostimulation in pediatric drug-resistant epilepsy: A systematic review and meta-analysis of seizure and non-seizure outcomes, safety, and predictors of response. Seizure
RNS® System Responsive stimulation of the thalamus for idiopathic generalized epilepsy: Results of the randomized controlled NAUTILUS trial through 18 months. Epilepsia
RNS® System Thalamocortical seizure onset patterns in drug-resistant focal epilepsy. Brain communications